drugset

drugset / Trial / NCT00150449

Determine Long-Term Safety and Tolerability of Pregabalin in Patients With Anxiety Disorders.

NCT00150449 ↗

Phase 3 Completed 511 enrolled Pfizer

Non-randomizedSingle-groupOpen-labelTreatment

Summary

Determine long-term safety and tolerability of pregabalin in patients with anxiety disorders.

Timeline

Start: 2001-01
Primary completion: —
Completion: 2006-03

Publications

Montgomery S, Emir B, Haswell H, Prieto R. Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerability. Curr Med Res Opin. 2013 Oct;29(10):1223-30. doi: 10.1185/03007995.2013.820694. Epub 2013 Aug 19.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Pregabalin	Small molecule	150 mg	—
Subject	Pregabalin	Small molecule	600 mg	—

Indications